Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.

The clinical features, cytogenetics and response to treatment have been examined in 180 infants (aged <1 year) with acute leukaemia; 118 with acute lymphoblastic leukaemia (ALL) and 62 with acute myeloid leukaemia (AML). Comparison of clinical features showed no difference in age or sex distr...

Full description

Bibliographic Details
Main Authors:	Chessells, J, Harrison, C, Kempski, H, Webb, D, Wheatley, K, Hann, I, Stevens, R, Harrison, G, Gibson, B
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
by: Webb, D, et al.
Published: (1999)

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1994)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1997)

Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party.
by: Secker-Walker, L, et al.
Published: (1997)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
by: Chessels, J, et al.
Published: (1997)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.
by: Harrison, G, et al.
Published: (2000)

Treatment of high risk leukaemia - Results of MRC childhood acute lymphoblastic leukaemia study MRC HR-1.
by: Kinsey, S, et al.
Published: (2002)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
by: Wheeler, K, et al.
Published: (1998)

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
by: Lilleyman, J, et al.
Published: (1992)

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.
by: Moor-Man, A, et al.
Published: (2009)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
by: Chessells, J, et al.
Published: (1995)

Improved outcome of acute myeloid leukaemia in Down's syndrome.
by: Craze, J, et al.
Published: (1999)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
by: Eden, O, et al.
Published: (2000)

Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.
by: Lilleyman, J, et al.
Published: (1994)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
by: Hann, I, et al.
Published: (2000)

Long survival in childhood lymphoblastic leukaemia.
by: Chessells, J, et al.
Published: (1987)

The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties.
by: Chessells, J, et al.
Published: (1998)

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
by: Chessells, J, et al.
Published: (1992)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
by: Grimwade, D, et al.
Published: (1998)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
by: Somervaille, T, et al.
Published: (2003)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
by: Wheeler, K, et al.
Published: (1998)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
by: Hann, I, et al.
Published: (1998)

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
by: Chessells, J, et al.
Published: (2001)

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.
by: Lilleyman, J, et al.
Published: (1997)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
by: Lilleyman, J, et al.
Published: (1988)

The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.
by: Burnett, A, et al.
Published: (2002)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
by: Harrison, G, et al.
Published: (2000)

Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
by: Wheeler, K, et al.
Published: (1996)

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
by: Chessells, J, et al.
Published: (1986)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
by: Chessells, J, et al.
Published: (1995)

Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.
by: Phillips, M, et al.
Published: (1991)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MIRD) clearance in childhood lymphoblastic leukaemia (ALL)
by: Moorman, A, et al.
Published: (2008)

Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
by: Moorman, A, et al.
Published: (2012)

Comparison of bone marrow transplantation with chemotherapy for high risk childhood acute lymphoblastic leukaemia in first remission.
by: Wheeler, K, et al.
Published: (1998)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
by: Eden, O, et al.
Published: (2000)

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.
by: Chessells, J, et al.
Published: (2002)

Cytogenetic-specific heterogeneity in the kinetics of minimal residual disease (MRD) clearance in childhood acute lymphoblastic leukaemia (ALL)
by: Moorman, A, et al.
Published: (2007)

Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia
by: Chilton, L, et al.
Published: (2017)

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
by: Dolan, G, et al.
Published: (1989)